Scott Naylor Holden
Physician at Dna Way, Ms 442B, South San Francisco, CA
License number
Colorado 39917
Issued Date
Sep 5, 2001
Renew Date
Jun 1, 2009
Expiration Date
May 31, 2011
Type
Physician
Address
Address
1 Dna Way, South San Francisco, CA 94080
Professional information
Treatment Of Her2-Positive Cancer With Paclitaxel And Trastuzumab-Mcc-Dm1
US Patent:
2014004, Feb 13, 2014
Filed:
Dec 7, 2011
Appl. No.:
13/991580
Inventors:
Barbara Klencke - San Francisco CA, US
Scott Holden - South San Francisco CA, US
Alice Guardino - South San Francisco CA, US
Betsy Althaus - South San Francisco CA, US
Scott Holden - South San Francisco CA, US
Alice Guardino - South San Francisco CA, US
Betsy Althaus - South San Francisco CA, US
Assignee:
GENENTECH, INC. - South San Francisco CA
International Classification:
A61K 47/48, A61K 39/395, A61K 31/337
US Classification:
4241331, 4241831
Abstract:
The present invention relates to combination therapy with paclitaxel, trastuzumab-MCC-DM1 and optionally, pertuzumab.